|Bid||7.20 x 1100|
|Ask||7.22 x 900|
|Day's Range||6.97 - 7.26|
|52 Week Range||1.48 - 8.05|
|Beta (5Y Monthly)||2.17|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug. 06, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||27.00|
Is (ALDX) Outperforming Other Medical Stocks This Year?
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that President and CEO Todd C. Brady, M.D., Ph.D., Chief Financial Officer Joshua Reed, and Chief Commercial Officer David McMullin will be participating in a fireside chat and hosting one-on-one meetings at Oppenheimer’s Fall Healthcare Life Sciences & MedTech Summit, which is being held in a virtual format.
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that senior management will be presenting and hosting one-on-one meetings at the following investor conferences: